Low-dose colchicine to prevent blood clots after heart valve replacement
Treatments studied
Part of Blood & lymphatic, Heart & circulation clinical trials.
This study tests whether a low dose of the medicine colchicine can help prevent blood clots after a TAVR procedure, which replaces a narrowed heart valve. If you've recently had TAVR, taking colchicine might lower your risk of clots.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 60 and 85 years old.
- You have had a successful TAVR procedure (a minimally invasive heart valve replacement).
- You are not allergic to colchicine and have not had bad reactions to it before.
- Your blood counts and kidney function are within acceptable ranges (they will check this).
- You are not taking certain medications that can interact with colchicine, like some heart, antibiotic, or stomach-acid drugs.
- You do not have serious digestive diseases, active cancer, or a weakened immune system.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether taking a low dose of colchicine, an anti-inflammatory medicine, after heart bypass surgery can help keep the new blood vessels open and working well. It may help reduce the chance of the bypass grafts failing.
This trial tests whether a low dose of the anti-inflammatory drug colchicine can help people who have recently had a heart attack or unstable angina. It aims to see if colchicine reduces the risk of future heart problems.
This study tests whether a low-dose medicine called colchicine can reduce inflammation and slow down artery blockages in people who have a specific gene change (TET2) and have recently had a heart attack. The goal is to see if it helps prevent future heart problems.
This trial tests whether taking colchicine around the time of surgery can reduce bad events after surgery in people at higher heart risk. It focuses on helping prevent complications related to inflammation after an operation.
This study tests whether taking colchicine (a common anti-inflammatory medication) before and after bypass heart surgery can prevent atrial fibrillation—an irregular heartbeat that sometimes occurs after surgery. Researchers hope this simple treatment might reduce complications and improve recovery.
This trial tests whether the drug colchicine can reduce inflammation after planned coronary artery bypass graft (CABG) surgery. It may help patients recover better by lowering inflammatory markers.
Hear when a new Transcatheter Aortic Valve Replacement trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.